BPC-157 vs TB-500: prices, identity and regulatory status (2026)
BPC-157 and TB-500 are compared here as separately listed products. TB-500's exact identity is not resolved to a public chemical record here, so this page does not state how the two relate chemically; BPC-157 is a 15-amino-acid peptide (C62H98N16O22). Check each supplier's specification and certificate of analysis. Neither product has a current in-stock price right now. BPC-157 has no Drugs@FDA application.
Read the TB-500 and thymosin beta-4 identity guide →
BPC-157 vs TB-500: current prices and packages
| Compared property | BPC-157 | TB-500 |
|---|---|---|
| Category | Healing | Healing |
| Compared package | 10mg | 10mg |
| Lowest current price | No current in-stock price | No current in-stock price |
| Price per labelled mg | — | — |
| Package sizes | 5mg, 10mg, 15mg, 20mg, 500mcg×60 | 5mg, 10mg, 20mg |
| Vendors with current prices | 0 | 0 |
| Form at this package | No listing | No listing |
| Stock | Out of stock | Out of stock |
Prices exclude shipping. The price per labelled mg is always given per mg, so different package sizes compare directly; it is shown only for single-compound vials and powders with a labelled mass. Blends, capsules, liquids and IU-labelled packages are compared by package total.
Identity, regulatory status and registered research
| Compared property | BPC-157 | TB-500 |
|---|---|---|
| Molecular formula | C62H98N16O22 | Not resolved |
| Molecular weight | 1419.5 g/mol | — |
| Sequence | H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH (15 residues) | — |
| CAS Registry Number | 137525-51-0 | — |
| Registered clinical trials | 3 (2 active) · Phase 2: 1, Phase 1: 2 | 1 (1 active) · Phase 2: 1 |
| Human intervention studies | 1 | None recorded |
| US regulatory status | No Drugs@FDA application (checked October 7, 2026) · Drugs@FDA search | No reviewed Drugs@FDA record |
Identity data: PubChem, FDA GSRS and EPA records; registry counts: ClinicalTrials.gov; status: Drugs@FDA. A matching name does not verify the contents of a supplier's lot.
Key human studies
BPC-157
- Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Alternative therapies in health and medicine, 2025
TB-500
No human intervention study is recorded in the research library for this identity.
TB-500 research profile →Studies are listed as records, newest first; they are not evidence that a research product is safe or effective.
Where to buy each compound
BPC-157
BPC-157 is a 15-amino-acid peptide studied in animal injury models. Published human observations also exist, but the small pilot reviewed here cannot establish general safety or clinical benefit.
No vendor has a current in-stock price for this package.
BPC-157 prices →Price history →TB-500
TB-500 requires an identity check: an analytical study uses that name for an acetylated seven-amino-acid fragment, while full-length thymosin beta-4 has 43 amino acids. These are different substances.
No vendor has a current in-stock price for this package.
TB-500 prices →Price history →Related comparisons
Questions
Automated price sources are scheduled daily; other sources are checked manually. Check the offer's last successful source timestamp. A code is shown when it is attached to an offer or affiliate link. The displayed price includes a discount only when that code is cart-verified and the discounted price is explicitly recorded; otherwise it is the vendor's listed price. Prices exclude shipping. Stock status is captured at the same time. Rankings are by displayed price, except that the labelled featured partner, LA Peptides, is pinned first; “Cheapest” always marks the lowest price. PeptideTech earns a commission when you buy through a link.
Full method →